WATSON 461 (Glipizide 10 mg)
Pill imprint WATSON 461 has been identified as Glipizide 10 mg.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 461 (Glipizide 10 mg)
- 10 mg
- 10.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
|NDC Code||Manufacturer / Repackager|
|63739-0117||McKesson Packaging Services|
|54569-3842||A S Medication Solutions LLC (repackager)|
|67544-0129||Prepak Systems Inc (repackager)|
|16590-0287||Stat RX USA LLC (repackager)|
|68258-1013||Dispensing Solutions Inc. (repackager)|
|66336-0662||Dispensing Solutions Inc. (repackager)|
|58016-0376||Southwood Pharmaceuticals Inc (repackager)|
|63874-0432||Altura Pharmaceuticals Inc (repackager)|
|54868-3319||Physicians Total Care Inc (repackager)|
|21695-0470||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
Glipizide is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...